ArticleCureus2025
The Overlap of Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction Syndrome: A Report of a Complex Case and Challenges With Its Management.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report the case of a 38-year-old female presenting with posterior reversible encephalopathy syndrome (PRES) overlapping with reversible cerebral vasoconstriction syndrome (RCVS), diagnosed based on clinical and imaging criteria. The patient exhibited progressive neurological symptoms, including headache, visual disturbances, and motor deficits. Brain magnetic resonance angiography revealed vasogenic edema and vascular stenoses. The complications included severe agitation, sympathetic hyperreactivity, and features suggestive of serotonin syndrome. The management focused on blood pressure control, symptom management, and medication adjustment. Despite significant improvement during hospitalization and rehabilitation, residual deficits persisted. This report highlights the complex interplay between PRES and RCVS, emphasizing the importance of serial neuroimaging, systematic medication reviews, and a multidisciplinary approach in managing such overlapping conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.